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ABSTRACT 
Objective: The aim of this study was to formulate the solid self-micro emulsifying dispersible tablets for promoting the dissolution of Piroxicam. 
Methods: Solubility study test was performed to know the solubility of various oil phase, surfactants, cosurfactants. Self-emulsifying grading test 
was done by visual grading system. Ternary phase diagrams and droplet size analysis test were performed to screen and optimize the Piroxicam-
self microemulsifying drug delivery system (SMEDS). Then microcrystalline cellulose (KG802) was added as a suitable adsorbent and dispersible 
tablet were prepared by wet granulation compression method. 
Results: The final composition of Piroxicam-SMEDS was oil phase (oleic acid, 23%), surfactant (Cremophor R H-40,61%), co-surfactant (PEG-
400,16%) based on the result of solubility test, self-emulsifying grading test, droplet size analysis and ternary phase diagrams. Microcrystalline 
cellulose (KG802) was selected based on dissolution study (98.35%) and added to liquid Piroxicam-Smeds formulation to form dispersible tablets. 
The in vitro dissolution study showed 98.02 % of drug release from Piroxicam-SMEDS tablets.  
Conclusion: Piroxicam–Self microemulsifying dispersible tablets have increased the solubility and bioavailability of the Piroxicam to a greater 
extent. SMEDS formulation can help the solubility of poorly water-soluble drugs.  
Keywords: Proxicam, solid self microemulsifying system, Dispersible tablet 
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INTRODUCTION 
The oral route of administration is most evident and well-fancied by 
every patient [1], which is economical and simplest route of 
administration and does not require any devices, which is helpful for 
self-medication [2]. In and around if we look 40% of new medication 
have poor solubility in water and ultimately results in poor oral 
bioavailability, which is the key challenge to formulate an oral 
dosage form [3, 4]. Since dissolution is the rate-limiting step, 
remodeling in the formulation is the correct approach to reinforce 
absorption and ultimately bioavailability of those medications [5, 6]. 
Several formulation approaches like complexation [7], solid 
dispersions [8], and nanosuspensions [9] are used to unravel this 
drawback; however, these approaches have some limitations like 
less stability and heavy 
According to Biopharmaceutical 
exorbitant methods. 
arrangement, Piroxicam (PX) is a 
non-steroidal anti-inflammatory drug (NSAIDs) which was classified 
under the category of Class II drug (low solubility and high 
porosity)[10]. Generally, the NSAIDs with an extended half-life and it 
is employed to treat pain related to rheumatism, degenerative 
arthritis, arthritis, and numerous contractile organ disorders. 
NSAIDs block enzyme, which ultimately results in inflammation, 
pain, and fever is reduced. Balakrishna et al. [11] suggested that the 
self-micro emulsifying drug delivery system (SMEDS) is the effective 
pharmaceuticaltechnologyto beat issues of drugs with low solubility 
and poor oral absorption. SMEDS contains isotropic mixtures of 
natural or artificial oils, surfactants, and co-surfactants. This 
framework not just improves sedate solubilization but also 
improves the deliverance and absorption features, as it then 
contains the dissolve style of the drug within the formulation; 
therefore, tiny droplet size giving an increased cover area. These 
systems effectively emulsify once exposed to channel fluids to make oil 
in water microemulsion with nanometric droplet size. Self-micro-
emulsifying drug delivery system (SMEDS) enhances in vitro 
dissolution and improves the in vivo absorption 
of lipotropic medication [12, 13]. SMEDS is the system with the 
droplet size starting from 20 to 200 nm [14, 15]. The 
solubilization capability was to research SMEDS for the nonsteroidal 
anti-inflammatory drug. The small-sized droplets of SMEDS supply a 
rise in the dissolution rate and bioavailability of medicine
Still, SMEDSs, which are fluid formulation, have some disadvantages, 
that some varieties of dosage forms are available, which have under 
the stability and low portability throughout the manufacturing 
method in which interaction occurs to filling as well as capsule shell. 
Hence surmount with these difficulties, the lipid formulation can be 
converted into a simple solid dosage form with the help of a proper 
adsorbent. Various types of hydrophilic as well as hydrophobic solid 
adsorbent could be used like Magnesium trisilicate, colloid silica, 
bentonite, dextran, etc have reached absorbing the liquid SMEDS and 
different techniques (e. g., extrusion-spheronization, spray drying, 
and granulation, etc.) [18], are utilized to serve into pellets, powders 
or different solid dosage form can be additionally filled into a 
capsule or can be packed into the tablet [19]. Among 
these 
 [16, 17]. 
ways, surface assimilation to solid carriers could be 
an easy and straight forward technique, giving a stable free-flowing 
S-SMEDS [20]. Density porous carriers with massive areas i.e. 
microcrystalline cellulose KG802 were employed to boost the 
dissolution rate of medicine like a beta-blocker
MATERIALS AND METHODS 
 [21]. Hence, the 
present study was focused to develop and evaluate Piroxicam loaded 
SMEDS using different oil and surfactant mixtures. 
Materials 
Piroxicam (99.2%) was received as a gift sample from Micro labs Pvt 
Ltd (Banglore, India). Castor oil, olive oil, corn oil was purchased 
from Alaba Analytical Laboratories (Surat, India). Oleic acid was 
purchased from Pas and Speciality Chemicals (Rajkot, India). Tween 
80 was purchased from Loba chemicals (Mumbai, India). Cremophor 
RH-40 was purchased from Zeel Pharmaceuticals (Mumbai, India), 
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OP-10 was purchased from K. K. Chempro India Private Ltd 
(Mumbai, India). Ethanol, butanol, isopropyl alcohol was purchased 
from Loba chemicals (Mumbai, India). PEG-400 was purchased from 
Montage Chemicals Pvt Ltd (Mumbai, India). Glycerol was purchased 
from Siddi Vinayak Industries (Ahmedabad, India). 
Methods 
Drug excipient compatibilities 
The fourier-transform infrared spectroscopy
The spectra of the drug, excipients, SMEDS, and self-
microemulsifying mouth dissolving film formulation formed were 
noted and recorded. Briefly, a solid sample was packed 
 (FTIR)  
together 
with regarding 100 mg dried potassium bromide (KBr) into a disc. 
For liquid specimens, few drops of the sample were dripped over the 
NaCl aperture plate and sandwiched it beneath the aperture 
plate, and made sure that there were no gas bubbles were at bay 
[22]. The sample endorsed the formation of a skinny liquid 
membrane between the 2 aperture plates. Thereafter, the sample 
was scanned for absorbance over the vary from 4000 to 400 (cm-1) 
wavenumbers. The obtained spectrum was then matched with the 
normal cluster frequencies of 
Selection of the self-microemulsified drug delivery system 
component 
PX. 
Solubility study of the PX 
PX dissolvability was known in oil, surfactant, and co-surfactant by 
the shake-flask technique. Castor oil, olive oil, oleic acid, corn oil 
were used as an oil, Tween 80, Cremophor R H-40, OP-10 were used 
as Surfactant and PEG-400, ethanol, glycol, Isopropyl alcohol, glycol, 
butanol, solutol were used as Co-surfactants. It was done by 
solubilizing an abundance amount of medication in 2 ml of the 
medium. The blend was then vortexed first and kept for 72 h at 25° 
in an orbital shaking hatchery (Dolphin) for solubilization.  
Self–emulsifying assess test 
After harmony, it was centrifuged in 10,000 rpm for 15 min. The 
supernatant fluid was diluted with 0.1 M methanolic HCl and 
medication were evaluated at 334 nm [23] by utilizing a UV 
spectrophotometer by placing a blank. The blank was then 
formulated by mixing oil, surfactant, and co-surfactant in 0.1 M HCl 
in methanol with the same dilution concerning the example [24]. 
According to Yang et al., elective oil (Castor oil, olive oil, oleic acid, 
corn oil), surfactants (Tween 80, Cremophor R H-40, OP-10), and co-
surfactants (Butanol, ethanol, solutol, glycerol, PEG 400, Isopropyl 
glycol) were homogenized pertaining to the result obtained during 
solubility obtained by 3:4:3 (w/w/w) in cells by vortexing for about 
5 min [25]. Next, place 1 ml of mixture into the 100 ml of water (37 
°C) using magnetic stirring to witness the emulsion development 
method and ultimate appearance. The event was classified into 5 
classes by a visual grading methods according to Anna et al. as first 
grade which expressed the accelerated emulsification formed in 1 
min and making a clear or light blue formation of microemulsion, 
second grade, which expressed the accelerated emulsification 
formed in 1 min and making a few clear and light whitish-blue 
emulsion, third grade which expressed the emulsification delayed 
within 2 min and making a bright white liquid, fourth grade which 
expressed the emulsification more delayed than of 2 min with dark 
dusky and lightly oil form, fifth grade which expressed neither the 
emulsification problems nor the presence of a large number of oil 
droplets [26]. 
Optimizing the formulated SMEDS 
The single-factor approaches were taken for optimizing the SMEDS. 
The required proportion of the oil, co-surfactant, and surfactant in 
liquid SMEDS were prepared by using droplet size (DS) and the 
Polydispersity-index (PDI) formed by microemulsion. The 
Microemulsion having a tiny droplet size of around 10 to100 nm can 
give an immense surface region that hinders the Para-glycoprotein 
interfered drug efflux and first-pass stomach metabolism, which also 
increases the GIT layer permeability. Prime, charge proportion of co-
surfactant and the surfactant were fixed to 3:1 and the mass 
percentage of oil was extended from 10 percent to 50 percent. PDI 
and DS formed of microemulsions were decided by employing a 
Zetasizer (Malvern Instruments, Ltd., UK). The weight percentage 
formed by the co-surfactant and surfactant was prolonged from 5% 
to 25% and 30% to 70%, and a weight percentage of oil was fixed at 
25%. 
PX (100 milligrams) were suspended to one ml of a blend carrying 
23% Oleic acid, 61% Cremophor–RH 40, and 16% PEG 400. The 
terminal mixture produced were then vortexed till the plain admix is 
achieved. The ultimate drug present in liquid SMEDS was 10% 
(w/w). The polydispersity index and particle sizes of the emulsion 
produced were estimated by Zetasizer. 
Development of the liquid SMEDS 
Preparation of PX-SMEDS dispersible tablet 
Based on the adsorption potential among various substances, 
including the percentage of PX discharged from the medium by 45 
min, the exact absorbing substances were calculated to make the 
Solid-SMEDS. 
Absorbing substances 
Development of PX-SMEDS dispersible doses
Diluent like MCC KG 802, disintegrating agent (PVPP-XL), lubricants 
such as aerosil were combined to the PX-SMEDS to develop PX micro 
emulsifying dispersible tablet by using the wet granulation and 
compression technology. Afterward in vitro dissolution were carried 
out to the PX compact self-microemulsifying dispersible tablet were 
examined. 
  
The in vitro dissolution of PX compact self-micro emulsifying 
dispersible tablets comprising 5 mg PX were conducted in the 
dissolution apparatus. Dissolution requirements were purified 
water, 0.1 M HCL solution with pH 6.7 phosphate buffer solution, 
37±0.5 °C, 50 rpm, 250 ml 4 ml of the medium was withdrawn at 1, 
5, 10, 20, 30, 45, 60, and 120 min by replacing an equivalent volume 
of a similar temperature blank.  
In vitro dissolution profile study 
The switched samples were drained by using a membrane filter of 
0.45 mm, then the filtrate obtained was weakened by methanol, and 
then by using HPLC the concentration of the PX present in diluent 
was assayed. When correlated with tablets, the dissolution profile 
obtained from free PX was further made in a similar dissolution 
condition. 
RESULTS AND DISCUSSION 
Drug excipient compatibilities study 
Fig. 1 noted the FTIR spectra of PX. According to Bunaciu et al., 
PX has two interconvertible crystalline forms, i. e the needle and 
cubic forms The IR 1629.90 cm–1 was accredited to the 
stretching of amide carbonyl groups of a cubic form, implying 
that the cubic form of PX was used. The main characteristic peak 
of PX was 3338 cm–1 for secondary amine N-H stretch, 3446.91 
cm–1 for O-H stretching, and 1182.40 cm–1 for S=O asymmetric 
stretching [27]. SMEDS formulation presented peaks at 1760.70 
cm–1 for C=O amide carbonyl group, 3446.91 cm–1 for N-H 
stretch, 3628.22 for O-H stretching, and 1215.19 for S=O 
asymmetric stretch.  
The N-H group of the amide in PX formed the hydrogen bond with a 
carboxyl group of SMEDS excipients (dissolvable and dilute form for 
PX) and this decreased electron density of nitrogen. This advances to 
the shifting of the C=O stretch of amide carbonyl. The IR spectra of 
formulation (SMEDS with drug) show the absence of exceptional 
changes in the position of the individual infrared absorption bands 
of the drug in formulation, proposing that there is no interaction 
between PX and excipients. 
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Fig. 1: FTIR spectra of pure PX and SMEDS accompanied with PX 
 
The solubility of PX 
Results of PX solubility in various oils have been displayed in the 
figure. It was recognized that oleic acid having a higher 
concentration of esters [28], the product illustrated greater 
solubility in oleic acid and hence it has been chosen as an oil phase. 
It is known that nonionic surfactants are stronger than ionic 
surfactants [29]. Reversible changes in intestinal mucosal 
permeability are expected to occur [30]. Those with HLB within 4.3 
and 16 have been tested. The final surfactant was chosen by its 
capacity to emulsify and deliver the transmittance. Cremophor-RH 
40 increased transmittance percentage, indicating a good ability to 
emulsify as displayed in fig. 2. In these surfactants, PX displayed 
better solubility in Cremophor RH 40 and was used for further 
testing. Co-surfactants were made to be screened for promoting the 
emulsification ability of the selected surfactant. The percentage of 
the transmittance and emulsification time were carried out using 
PEG 400 amongst all the co-surfactants screened, PEG 400 showed 
the highest percent transmittance when used along with Cremophor 
RH 40. Cremophor RH 40 having higher HLB i.e. 15. According to 
Zeng et al. more HLB values of surfactant lead to increase active 
dispersion and more precise emulsion droplet size on an extension 





Fig. 2: The solubility studies of PX in various oil, Surfactant, Co-surfactant 
Visible grading effects concerning microemulsions offered over 
various SMEDS compounds have been given in table 1, having PEG 
400 set as co-surfactant. Later, surfactants like Cremophor RH 40, 
OP-10, and Tween 80 were combined amidst all oils. The marked 
surfactants, which revealed the poor capacity to form a 
microemulsion, were graded as D and E and which showed the good 
capacity of forming microemulsion were graded A and B [32]. 
However, Cremophor R H-40 produced fine microemulsion among 
all, as most of it got visual class as B. Hence Cremophor R H 40 was 
chosen as a surfactant in the study, whereas castor oil, olive oil, oleic 
acid, and corn oil were approximately elected as an oil phase for the 
further selection procedure. 
Self-emulsifying assesses test 
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Table 1: Visual grading effects obtained by a compatability study having a ratio of surfactant, oil, and co-surfactant fixed at 4:3:3(w/w/w) 
S. No. Oil Cremophor RH-40 OP-10 Tween80 
1 Oleicacid B B D 
2 Castoroil B E E 
3 Oliveoil B E D 
4 Cornoil B D D 
Note: G
 
ood capacity of forming microemulsion (A and B), Poor capacity of forming microemulsion (C,D and E) 
Ternary phase charts concerning the oils (olive oil, castor oil, oleic 
acid, corn oil), surfactant ie, Cremophor RH-40, and co-surfactant 
PEG 400 were constructed without the presence of PX to recognize 
the self-emulsifying areas [33]. The highest microemulsion area 
was seen at oleic acid (fig. 3 C) which was selected as an oil phase. 
Hence the Oleic acid-Cremophor RH-40, PEG 400 lends was chosen 
as a liquid SMEDS for PX and they were chosen for additional 
study. 
Preparation of ternary phase diagram 
 
 
Fig. 3: Ternary phase diagram formed of variousoils, surfactant, Co-surfactant; A. cornoil, cremophor RH-40, PEG400; B. Oleicacid, 
Cremophor RH-40, PEG400; C. Castoroil, Cremophor RH-40, PEG400; D. Olive oil, Cremophor RH-40, PEG400 
 
The droplet area of the emulsion will be an influential factor during 
self-emulsification execution as it will define the degree and the 
extent of a drug discharge and absorption [34]. While increasing the 
percentage of the oil phase during the formulation (table 2), DS and 
PDI will increase, while the increasing percentage of surfactant DS 
and PDI will be decreased. When the co-surfactant level is more than 
15%, both PDI and DS have progressed. As the Km increases, PDI 
and DS slowly decrease. Hence accepted optimized formulation for 
PX-SMEDS would be surfactant (Cremophor-RH 40) 60%, oil phase 
(Oleic acid) 25%, co-surfactant (PEG 400) 15%. 
Optimizing the formulated SMEDS 
 
Oil 
Table 2: Influence of formulation on polydispersity index and particle size 
Surfactant Co-surfactant P. S±SD* (nm) PDI±SD* 
10 67.5 22.5 8.92±0.82 0.17±0.011 
20 60 20 14.45±0.85 0.23±0.025 
25 56.25 18.75 16.69±0.96 0.23±0.023 
30 52.5 17.5 42.38±0.56. 0.44±0.015 
40 45 15 126.36±1.01 0.35±0.025 
50 37.5 12.5 135.4±0.69 0.68±0.089 
25 30 45 82.6±0.98 0.38±0.023 
25 30 44 81.5±0.96 0.35±0.011 
25 50 25 47.5±0.36 0.61±0.089 
25 60 15 14.98±0.32 0.13±0.056 
25 70 05 12.01±0.69 0.11±0.042 
25 70 05 14.25±0.01 0.22±0.054 
25 65 10 13.23±0.75 0.12±0.035 
25 60 15 14.2±0.21 0.19±0.053 
25 55 20 24.3±0.36 0.54±0.101 
25 50 25 60.9±1.89 0.65±0.069 
Note: *SD: Standard Deviation, n=3, *P. S: Particle size, *PDI: Polydispersity Index. 
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During the experiment, it was found that the absorption potential 
offered by insoluble substances were greater than that offered by 
soluble materials (fig. 4). Through our analysis silica had the 
greatest absorption potential; the percentage of PX released during 
45 min was lesser to 79 percent, whereas the percentage of PX 
discharged from the MCC KG802 would exceed 98.35±0.25% (table 
3). The reception capability of the MCC KG 802 was 1 g. Hence, MCC 




Fig. 4: The absorption potential obtained by 1 gram of soluble and insoluble materials (mean±SD n=3) 
 
Table 3: The dissolution (%) obtained by different types of solid materials during 45 min 





Sio 76.22±1.04 2 
Note: *Data represented as mean±SD (n=3)  
 
In vitro drug release study 
For L-SMEDS, in vitro dissolution studies showed around 81.23% 
drug release over 5 min and over 98.97 % within 45 min. For the 
S-SMEDS batch, the in vitro dissolution studies showed (fig. 5) 
around 82.59 % in 5 min and 98.02 % in 45 min. Plain drug 
revealed very less release of around 35.51 % after 120 min in 0.1 
N HCL. Through in vitro. dissolution studies, it was shown that the 
S-SMEDS
 
had improved in the rate of drug release than that of pure 
drug. 
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Fig. 5: In vitro dissolution study of PX, S-SMEDS, and L-SMEDS 
CONCLUSION 
From the above experiment, the optimized combination of the liquid 
PX-SMEDS was oil phase (Oleic acid) 23%, surfactant (Cremophor 
RH-40) 61%, co-surfactant (PEG 400) 16% upon the result obtained 
by self-emulsifying assess test, solubility test, ternary phase 
diagrams test and droplet size analysis. The final drug present in the 
liquid SMEDS was comprised of 10% (w/w) An advantageous 
adsorbent (microcrystalline cellulose MCC KG.802) was affixed to 
liquid PX-SMEDS to formulate the dispersible tablets utilizing the 
wet granulation compression technique PX self-micro emulsifying 
dispersible tablets has developed the solubility as well as the 
bioavailability of inadequately soluble drugs like PX, and would 
immediately disperse it into a tiny solid droplet in a dispersion 
phase. Thus, the above experiment has contributed to the use of the 
solid self-micro emulsifying system to increase solubility as well as 
the dissolution of low water-soluble drugs such as PX in the 
development of future medicinal experimentation. 
FUNDING 
Nil 
AUTHORS CONTRIBUTIONS  
All authors have contributed equally. 
CONFLICT OF INTERESTS 
The author has no conflict of interest to declared. 
REFERENCES 
1. Reinholz J, Landfester K, Mailänder V. The challenges of oral drug 
delivery via nanocarriers. Drug Delivery 2018;25:1694-705. 
2. Bennadi D. Self-medication: a current challenge. J Basic Clin 
Pharm 2013;5:19-23.  
3. Obitte NC, Rohan LC, Adeyeye CM, Parniak MA, Esimone CO. 
The utility of self-emulsifying oil formulation to improve the 
poor solubility of the anti HIV drug CSIC. AIDS Res Ther 
2013;10:14. 
4. Yang M, Gong W, Wang Y, Shan L, Li Y, Gao C. Bioavailability 
improvement strategies for poorly water-soluble drugs based 
on the supersaturation mechanism: an update. J Pharm Pharm 
Sci 2016;19:208-25. 
5. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental 
and computational approaches to estimate solubility and 
permeability in drug discovery and development settings. Adv 
Drug Delivery Rev 1997;23:3-25. 
6. Pouton CW. Formulation of poorly water-soluble drugs for oral 
administration. physicochemical and physiological issues and 
the lipid formulation classification system. Euro J Pharm Sci 
2006;1:278-87. 
7. Chaudhary VB, Patel JK. Cyclodextrin inclusion complex to 
enhance the solubility of poorly water-soluble drugs: a rev. Int J 
Pharm Sci Res 2013;4:68. 
8. Sridhar I, Doshi A, Joshi B, Wankhede V, Doshi J. Solid 
dispersions: an approach to enhance solubility of poorly water 
soluble drug. J Sci Inno Res 2013;2:685-94. 
9. Krishna KB, Prabhakar C. A review on nanosuspensions in drug 
delivery. Int J Pharma Bio Sci 2011;2:549-8. 
10. DV Gowda, G Parthasarathi, HG Shivakumar. Comparative 
bioavailability of two marketed piroxicam formulations in 
healthy human volunteers. Ind Drugs 2003;40:573-6. 
11. Singh SK, Verma PR, Razdan B. Development and 
characterization of a lovastatin-loaded self-microemulsifying 
drug delivery system. Pharm Dev Tech 2010;15:469-83. 
12. Hong JY, Kim JK, Song YK, Park JS, Kim CK. A new self-
emulsifying formulation of itraconazole with improved 
dissolution and oral absorption. J Controlled Release 
2006;110:332-8. 
13. Gohel MC, Nagori SA. Fabrication and evaluation of hydrogel 
thickened microemulsion of ibuprofen for topical delivery. Ind J 
Pharm Educ Res 2010;44:189-96. 
14. Kuentz M. Lipid-based formulations for oral delivery of 
lipophilic drugs. Drug Dis Today: Tech 2012;9:97-104. 
15. Li S, Madan P, Lin S. Effect of ionization of drug on drug 
solubilization in SMEDS prepared using capmul MCM and 
caprylic acid. Asian J Pharm Sci 2017;12:73-82. 
16. Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. Preparation 
and in vitro characterization of a eutectic-based semisolid self-
nano emulsified drug delivery system (SNEDDS) of ubiquinone: 
mechanism and progress of emulsion formation. Intern J Pharm 
2002;235:247-65. 
17. Wang YP, Gan Y, Zhang XX. Novel gastroretentive sustained-
release tablet of tacrolimus based on self-microemulsifying 
mixture: in vitro evaluation and in vivo bioavailability test. Acta 
Pharmacol Sin 2011;32:1294. 
18. Gupta S, Kesarla R, Omri A. Formulation strategies to improve the 
bioavailability of poorly absorbed drugs with special emphasis 
on self-emulsifying systems. ISRN Pharm 2013;26:20-3. 
19. DV Gowda, Mohammed S Khan, Afifa Bathool. Formulation and 
characterization of piroxicam floating microspheres for 
prolonged gastric retention. Der Pharm Lett 2010;2:217–22.  
20. Singh B, Bandopadhyay S, Kapil R, Singh R, Katare OP. Self-
emulsifying drug delivery systems (SEDDS): formulation 
development, characterization, and applications. Critical Rev 
Thera Drug Carrier Sys 2009;26:5. 
21. Bahl D, Bogner RH. Amorphization of indomethacin by co-
grinding with Neusilin US2:amorphization kinetics, physical 
stability and mechanism. Pharm Res 2006;23:2317-25. 
22. Suresh S, Gunasekaran S, Srinivasan S. Vibrational spectra (FT-
IR, FT-Raman), frontier molecular orbital, first 
hyperpolarizability, NBO analysis and thermodynamics 
properties of piroxicam by HF and DFT methods. Spect Acta 
Part A: Mole Biomol Spec 2015;138:447-59. 
23. Dhage MA, Chhabra GS, Banerjee SK. Development and 
validation of UV-spectrophotometric method for PX in bulk and 
pharmaceutical formulation. J Chem Pharm Res 2011;3:765-9. 
24. Kallakunta VR, Bandari S, Jukanti R, Veerareddy PR. Oral self-
emulsifying powder of lercanidipine hydrochloride: 
formulation and evaluation. Pow Tech 2012;221:375-82. 
25. Date AA, Nagarsenker MS. Design and evaluation of self-nano 
emulsifying drug delivery systems (SNEDDS) for cefpodoxime 
proxetil. Int J Pharm 2007;329:166-72. 
26. Czajkowska Kosnik A, Szekalska M, Amelian A, Szymanska E, 
Winnicka K. Development and evaluation of liquid and solid 
self-emulsifying drug delivery systems for atorvastatin. 
Molecules 2015;20:21010-22. 
27. Kumar RS. Ghosh, design, optimisation and evaluation of 
piroxicam fast dissolving tablets employing starch tartrate-a 
new superdisintegrant. Int J Appl Pharm 2019;11:89-97. 
28. Bachhav AA, Ahire SA, Jadhav AG. Preformulation study of 
piroxicam. Inter J Pharm Sci Res 2019;10:811-8. 
29. Nazzal S, Smalyukh I, Lavrentovich OD, Khan MA. Preparation 
and in-vitro characterization of aeutectic based semisolid self-
nanoemulsified drug delivery system (SNEDDS) of ubiquinone: 
mechanism and progress of emulsion formation. Int J Pharm 
2002;235:247-65. 
30. Swenson ES, Milisen WB, Curatolo W. Ntestinal permeability 
enhancement: efficacy, acute local toxicity and reversibility. 
Pharm Res 1994;11:1132-42. 
31. Zeng L, Xin X, Zhang Y. Development and characterization of 
promising cremophor EL-stabilized o/w nanoemulsions 
containing short-chain alcohols as a cosurfactant. RSC 
Advances 2017;7:19815-27. 
32. Sahoo SK, Suresh P, Acharya U. Design and development of self-
microemulsifying drug delivery systems (smedds) of 
telmisartan for enhancement of in vitro dissolution and oral 
bioavailability in rabbit. Int J Appl Pharm 2018;10:117-26. 
33. Nasr A, Gardouh A, Ghonaim H. Abdelghany and Ghorab, Effect 
of oils, surfactants and cosurfactants on phase behavior and 
physicochemical properties of self-nanoemulsifying drug 
delivery system (snedds) for irbesartan and olmesartan. Int J 
Appl Pharm 2016;8:13-24. 
Gowda et al. 
Int J App Pharm, Vol 13, Issue 2, 2021, 127-133 
133 
34. Son HY, Chae BR, Choi JY, Shin DJ, Goo YT, Lee ES, et al. 
Optimization of self-microemulsifying drug delivery system for 
phospholipid complex of telmisartan using D-optimal mixture 
design. PloS one 2018;13:1254. 
 
